COLD, COUGH, AND SORE THROAT REMEDIES MARKET ANALYSIS

Cold, Cough, and Sore Throat Remedies MarketSize and Trends

The global cold, cough, and sore throat remedies market is estimated to account for US$ 36,325.0 Mn in terms of value in 2019 and is expected to reach US$ 46,869.6 Mn by the end of 2027.

Asia Pacific region held dominant position in the global cold, cough, and sore throat remedies market in 2018, accounting for 37.1% share in terms of value, followed by Europe.

Antihistamines segment in the global cold, cough, and sore throat remedies market was valued at US$ 9,323.8 Mn in 2018 and is expected to reach US$ 12,934.4 Mn by 2027 at a CAGR of 3.6% during the forecast period.

Market Trends/Key Takeaways

Misuse of OTC cough medicine among young population has witnessing a decreasing trend. For instance, according to the 2019 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, the number of teens using OTC cough medicine containing dextromethorphan to get high decreased compared to that in 2006.

Players in the market are focused on launching products specially designed for children. For instance, in October 2019, Vicks launched its newest cold medication specially formulated for children that include Vicks Children’s Cough & Congestion. It is free from artificial additives, artificial dyes and flavors, and high fructose corn syrup and alcohol.